Shanghai Haoyuan Chemexpress Co., Ltd.

Shanghai Stock Exchange 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd. Market Capitalization on January 27, 2025: USD 1.11 B

Shanghai Haoyuan Chemexpress Co., Ltd. Market Capitalization is USD 1.11 B on January 27, 2025, a 39.93% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Shanghai Haoyuan Chemexpress Co., Ltd. 52-week high Market Capitalization is USD 1.36 B on November 11, 2024, which is 22.29% above the current Market Capitalization.
Shanghai Haoyuan Chemexpress Co., Ltd. 52-week low Market Capitalization is USD 377.62 M on July 04, 2024, which is -66.07% below the current Market Capitalization.
Shanghai Haoyuan Chemexpress Co., Ltd. average Market Capitalization for the last 52 weeks is USD 781.63 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 688131.SS

Shanghai Haoyuan Chemexpress Co., Ltd.

CEO	Mr. Baofu Zheng
IPO Date	June 8, 2021
Location	China
Headquarters	No. 3 Building, No. 1999
Employees	3,370
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shanghai Haoyuan Chemexpress Co., Ltd. researches and develops pharmaceutical intermediates and small molecule drugs. It manufactures APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Key trends

Past 5 years